In the Media

Forbes contributor Farah Qaiser spotlights how a team of MIT researchers developed a CRISPR-based diagnostic tool to help predict kidney organ transplant rejections. Qaiser writes that in the future, “the tool may become the go-to pee-in-a-cup option to monitor viral infections and early signs of transplant rejection in patients with kidney transplants.”